Mountain View, CA, United States of America

Ivan Tzvetanov

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Ivan Tzvetanov in Vascular Technology

Introduction

Ivan Tzvetanov is a notable inventor based in Mountain View, CA (US), recognized for his contributions to the field of vascular technology. He holds a total of 3 patents that focus on absorbable intravascular devices designed to enhance blood flow and maintain vascular integrity.

Latest Patents

Tzvetanov's latest patents include innovative designs for absorbable intravascular devices that shorten upon expansion, creating space for vascular movement. One of his key inventions is a multi-element vascular stent that can be used to maintain or enhance the patency of blood vessels. This stent is particularly advantageous for treating long lesions in tortuous peripheral blood vessels. By utilizing multiple, separate stent elements that are balloon-expandable, the stent offers greater strength and flexibility compared to traditional designs. Another significant patent involves devices that exhibit their greatest radial strength at their nominal diameters, ensuring effective blood flow maintenance through the blood vessel.

Career Highlights

Ivan Tzvetanov is currently associated with Efemoral Medical Inc., where he continues to innovate in the field of medical devices. His work focuses on developing advanced solutions that address complex vascular challenges.

Collaborations

Tzvetanov collaborates with notable professionals in the industry, including Lewis B Schwartz and Alex Etrada, contributing to the advancement of vascular technology.

Conclusion

Ivan Tzvetanov's innovative work in vascular technology showcases his commitment to improving medical devices for better patient outcomes. His patents reflect a deep understanding of the complexities involved in vascular treatments and highlight his role as a significant contributor to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…